Stockreport

New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Third-Line+ Treatment – – Data Builds on Previous Evidence on the Association Between Timely Infusion and Patient Outcomes – – Preliminary Results Supporting Safety [Read more]